The Effectiveness of Kinesiotaping and Inactivation of Trigger Points in Chronic Myofascial Pain of TMD
CompletedNot applicableNCT03398486
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In patients with a long-lasting TMD syndrome, especially of a muscular nature, palpation examination can locate the trigger points of pain (TrP) in the chewing muscles, i.e., the nodules in the shape of bumps the size of rice or pea grains. Kinesiotaping (KT) is considered as an intervention method that can be used to release latent myofascial trigger points. It is a method that involves applying specific tapes to the patient's skin surface in order to use the natural self-healing processes of the body. The aim of the study was to evaluate the effect of Kinesiotaping methods and inactivation of Trigger Points on nonpharmacological elimination of pain in patients with functional disorders of the masticatory motor system.
Study details
- Official title
- Evaluation of the Effectiveness of Kinesiotaping and Inactivation of Trigger Points in Chronic Myofascial Pain of Temporomandibular Joint Dysfunction
- Conditions
- Myofascial Pain
- TMD
- Interventions
- Diagnostic test: Kinesiotaping
- Diagnostic test: inactivation of trigger points (TrP)
- Sponsor
- Pomeranian Medical University Szczecin
- Collaborators
- Ministry of Health, Poland
- Start date
- 2016-10-02
- Primary completion
- 2017-06-15
- Sex
- All
- Age range
- from 18 Years to 35 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age between 18-35 years, both male and female * Provide informed consent to participate in the study; * Having a diagnosis of muscular pain TMD(Temporomandibular Disorders) according to group -I A, axis I RDC/TMD(Research Diagnostic Criteria) * Visual analogic scale (VAS) score from 4 to 10 for 14 days * Not have history of alcohol or drugs abuse within the past 6 months as self-reported * Not use ot carbamazepine (or similar) within the past 6 months as self reported * Not have history of neurosurgery as self-reported * Not have history of major psychiatric disorders such as schizophrenia and bipolar disorder * Not have any other previously diagnosed disorder with symptoms similar to the TMD, such as fibromyalgia. Exclusion Criteria: * One absence during therapeutic sessions;
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03398486